Imcivree - Commercial

Prior Authorization, Quantity Limit

Substrate Reduction Therapy - Medicaid

Prior Authorization, Quantity Limit

Substrate Reduction Therapy - Commercial

Prior Authorization, Quantity Limit

tel XXX

QP52-21 Commercial and MHCP Pharmacy Benefit Exclusion for AduhelmTM

QP53-21 Medical Drug Exclusion List Update – for Euflexxa

QP2R1-21 Update for New to Market Medical Drugs: Aducanumab, Casimersen, Evinacumab, Idecabtagene Vicleucel, and Pegunigalsidase Alfa

Special Transportation Ride Request Form

Common Carrier Ride Request Form

Special Transportation Ride Request Form - Care Coordinator